T-cell selection and intestinal homeostasis.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 4028094)

Published in Immunol Rev on May 01, 2014

Authors

Teresa L Ai1, Benjamin D Solomon, Chyi-Song Hsieh

Author Affiliations

1: Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA.

Articles cited by this

(truncated to the top 100)

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60

Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29

Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med (2007) 15.17

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature (2008) 14.26

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science (2007) 12.79

Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol (2001) 12.00

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med (2007) 11.82

Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 11.80

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07

Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 10.53

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity (2008) 10.26

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 9.81

Retinoic acid imprints gut-homing specificity on T cells. Immunity (2004) 9.76

Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol (2012) 9.75

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol (2010) 9.72

Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 8.97

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity (2010) 8.90

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med (1996) 8.54

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (2013) 8.53

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell (2007) 8.42

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol (2009) 8.32

Plasticity of CD4+ T cell lineage differentiation. Immunity (2009) 8.08

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med (2004) 8.00

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86

Human nutrition, the gut microbiome and the immune system. Nature (2011) 7.77

Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol (2007) 7.64

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature (2010) 7.50

Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature (2010) 6.87

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature (2013) 6.77

Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature (2009) 6.65

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood (2005) 6.49

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 6.45

Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature (2011) 6.43

CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science (2009) 6.14

The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med (2008) 6.07

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science (2011) 6.01

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med (2003) 6.00

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med (2011) 5.99

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A (2008) 5.97

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med (2007) 5.96

Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity (2006) 5.91

Peripheral education of the immune system by colonic commensal microbiota. Nature (2011) 5.80

Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol (2010) 5.57

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47

Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science (1999) 4.97

Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2009) 4.90

Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity (2011) 4.86

Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science (2009) 4.80

Control of intestinal inflammation by regulatory T cells. Immunol Rev (2001) 4.73

Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med (2006) 4.53

Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med (2005) 4.47

Induction and molecular signature of pathogenic TH17 cells. Nat Immunol (2012) 4.43

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med (2004) 4.35

Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature (2012) 4.33

Herpesvirus latency confers symbiotic protection from bacterial infection. Nature (2007) 4.27

Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A (2009) 4.25

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature (2011) 4.07

Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity (2006) 4.06

Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 3.91

In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med (2008) 3.85

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med (2009) 3.78

A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity (2011) 3.76

Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science (2013) 3.74

German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med (2011) 3.69

Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med (2012) 3.40

Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol (2009) 3.38

Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature (2009) 3.25

Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity (2008) 3.25

OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J Exp Med (1990) 3.23

Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med (2012) 3.20

Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity (2012) 3.18

The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol (2011) 3.13

An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity (2011) 3.11

Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity (2011) 3.06

Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol (1997) 3.05

Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med (2012) 2.97

Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature (2013) 2.95

Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J Immunol (2011) 2.80

Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature (2012) 2.76

Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature (2013) 2.75

Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med (2008) 2.68

Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med (1999) 2.61

Thymic emigration revisited. J Exp Med (2007) 2.60

Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut (2010) 2.60

Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol (2008) 2.50

GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice. J Clin Invest (2011) 2.43

mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature (2013) 2.38

Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol (2011) 2.34

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity (2002) 2.20

TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes. J Exp Med (2009) 2.18

Re(de)fining the dendritic cell lineage. Nat Immunol (2012) 2.17

Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol (2013) 2.13

Articles by these authors

Peripheral education of the immune system by colonic commensal microbiota. Nature (2011) 5.80

A two-step process for thymic regulatory T cell development. Immunity (2008) 4.29

Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity (2008) 3.56

Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol (2009) 3.38

Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell (2012) 3.21

Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med (2008) 2.68

A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity (2012) 2.10

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol (2009) 1.75

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol Immunother (2012) 1.55

A broad range of ophthalmologic anomalies is part of the holoprosencephaly spectrum. Am J Med Genet A (2011) 1.44

Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res (2006) 1.39

The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis. Hum Mutat (2009) 1.32

CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J Immunol (2010) 1.19

Rare development of Foxp3+ thymocytes in the CD4+CD8+ subset. J Immunol (2009) 1.14

Becoming self-aware: the thymic education of regulatory T cells. Curr Opin Immunol (2010) 1.12

T cell tolerance and immunity to commensal bacteria. Curr Opin Immunol (2012) 1.06

The clinical content of preconception care: women with chronic medical conditions. Am J Obstet Gynecol (2008) 1.04

Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. J Exp Med (2010) 1.03

Holoprosencephaly and agnathia spectrum: Presentation of two new patients and review of the literature. Am J Med Genet C Semin Med Genet (2010) 1.01

Missense substitutions in the GAS1 protein present in holoprosencephaly patients reduce the affinity for its ligand, SHH. Hum Genet (2011) 0.98

Thymic and peripheral differentiation of regulatory T cells. Adv Immunol (2011) 0.95

A common genetic network underlies substance use disorders and disruptive or externalizing disorders. Hum Genet (2012) 0.92

CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β. J Immunol (2013) 0.92

Cyclopia (synophthalmia) in Smith-Lemli-Opitz syndrome: First reported case and consideration of mechanism. Am J Med Genet C Semin Med Genet (2010) 0.90

Analysis of FOXF1 and the FOX gene cluster in patients with VACTERL association. Eur J Med Genet (2011) 0.89

Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J Immunol (2010) 0.88

GWAS reveals new recessive loci associated with non-syndromic facial clefting. Eur J Med Genet (2012) 0.88

Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. Eur J Immunol (2013) 0.87

Holoprosencephaly and ectrodactyly: Report of three new patients and review of the literature. Am J Med Genet C Semin Med Genet (2010) 0.87

T cell immunodominance is dictated by the positively selecting self-peptide. Elife (2014) 0.86

VATER/VACTERL association: identification of seven new twin pairs, a systematic review of the literature, and a classical twin analysis. Clin Dysmorphol (2012) 0.86

Inheritance of the VATER/VACTERL association. Pediatr Surg Int (2012) 0.86

Long-term outcomes of adults with features of VACTERL association. Eur J Med Genet (2010) 0.84

Holoprosencephaly: a guide to diagnosis and clinical management. Indian Pediatr (2011) 0.83

Analysis of cardiac anomalies in VACTERL association. Birth Defects Res A Clin Mol Teratol (2013) 0.80

Palatal and oral manifestations of Muenke syndrome (FGFR3-related craniosynostosis). J Craniofac Surg (2012) 0.80

Evidence for SHH as a candidate gene for encephalocele. Clin Dysmorphol (2012) 0.79

Pillars article: development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. 1993. Science 260(5107): 547-549. J Immunol (2008) 0.79

Holoprosencephaly in a family segregating novel variants in ZIC2 and GLI2. Am J Med Genet A (2011) 0.79

Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses. Childs Nerv Syst (2012) 0.79

Analysis of renal anomalies in VACTERL association. Birth Defects Res A Clin Mol Teratol (2014) 0.78

New syndrome of congenital circumferential skin folds associated with multiple congenital anomalies. Pediatr Dermatol (2011) 0.77

Hearing loss in syndromic craniosynostoses: introduction and consideration of mechanisms. Am J Audiol (2014) 0.77

Holoprosencephaly and craniosynostosis: A report of two siblings and review of the literature. Am J Med Genet C Semin Med Genet (2010) 0.77

Talocalcaneal coalition in Muenke syndrome: report of a patient, review of the literature in FGFR-related craniosynostoses, and consideration of mechanism. Am J Med Genet A (2013) 0.76

Introduction to the American Journal of Medical Genetics Part C on holoprosencephaly. Am J Med Genet C Semin Med Genet (2010) 0.76

Minimal evidence for a direct involvement of twisted gastrulation homolog 1 (TWSG1) gene in human holoprosencephaly. Mol Genet Metab (2010) 0.76

Epilepsy in Muenke syndrome: FGFR3-related craniosynostosis. Pediatr Neurol (2012) 0.75

Molecular analysis of the Noggin (NOG) gene in holoprosencephaly patients. Mol Genet Metab (2012) 0.75

Patients within the Broad Holoprosencephaly Spectrum have Distinct and Subtle Ophthalmologic Anomalies: Response to Khan. Am J Med Genet A (2012) 0.75

Holoprosencephaly-polydactyly/pseudotrisomy 13: a presentation of two new cases and a review of the literature. Clin Dysmorphol (2012) 0.75

Genetic-environmental interaction in a unique case of Muenke syndrome with intracranial hypertension. Childs Nerv Syst (2011) 0.75

Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism. J Pediatr Endocrinol Metab (2014) 0.75